Zhuang, H., Shi, S., Guo, Y., & Wang, Z. (2019). Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor. J Cancer.
Chicago-стиль цитированияZhuang, Hongqing, Siyu Shi, Yihang Guo, and Zhongqiu Wang. "Increase of Secondary Mutations May Be a Drug-resistance Mechanism for Lung Adenocarcinoma After Radiation Therapy Combined With Tyrosine Kinase Inhibitor." J Cancer 2019.
MLA-цитированиеZhuang, Hongqing, Siyu Shi, Yihang Guo, and Zhongqiu Wang. "Increase of Secondary Mutations May Be a Drug-resistance Mechanism for Lung Adenocarcinoma After Radiation Therapy Combined With Tyrosine Kinase Inhibitor." J Cancer 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.